Global

Oncology Experts

Sandeep Burma

Associate Professor
Radiation Oncology
UT Southwestern Medical Center
United States of America

Biography

Dr. Sandeep Burma obtained his Ph.D. in Molecular Biology from the National Institute of Immunology, New Delhi, India in 1995. After postdoctoral training at Yale University, Pennsylvania State University and Los Alamos National Laboratory, he joined the Lawrence Berkeley National Laboratory as a Scientist Biologist in 1999. He joined the UT Southwestern Medical Center in 2005 where he is currently Associate Professor of Radiation Oncology. Dr. Burma is member of the Harold C. Simmons Comprehensive Cancer center and the Cancer Biology and Genetics, Development & Disease graduate programs of UT Southwestern. Research in the Burma laboratory is focused on the responses of mammalian cells to DNA double-strand breaks (DSBs), collectively called the DNA damage response (DDR). These responses are of paramount importance in the field of cancer biology - on one hand, DSBs cause cancer, while, on the other hand, these breaks are induced by ionizing radiation or chemotherapies commonly used to treat the disease. The Burma lab is involved in studying DDR events triggered by ionizing radiation and their carcinogenic and cancer therapeutic implications.

Research Interest

DNA double-strand breaks - sensing, signaling and repair Glioblastoma radioresistance - genetic basis and therapeutic targeting Radiation-induced gliomagenesis - genetic events underlying transformation

Publications

  • DNA double-strand breaks cooperate with loss of Ink4 and Arf tumor suppressors to generate glioblastomas with frequent Met amplification. Camacho CV, Todorova PK, Hardebeck MC, Tomimatsu N, Gil Del Alcazar CR, Ilcheva M, Mukherjee B, McEllin B, Vemireddy V, Hatanpaa K, Story MD, Habib AA, Murty VV, Bachoo R, Burma S Oncogene 2014 Mar

  • Immunofluorescence-based methods to monitor DNA end resection. Mukherjee B, Tomimatsu N, Burma S Methods Mol. Biol. 2015 1292 67-75

  • Augmented HR Repair Mediates Acquired-temozolomide Resistance in Glioblastoma. Gil Del Alcazar CR, Todorova PK, Habib AA, Mukherjee B, Burma S Mol. Cancer Res. 2016 Jun

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America